Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Transgene S.A.
Approvals by FDA also include revised container and consumer information labeling for J&J's Men’s Rogaine to align with labeling for Women’s Rogaine; bonus-pack labeling for Bayer AG’s Aleve; and
Perrigo has moved to allay more serious concerns around its generic ProAir inhaler device, but concedes that it is highly unlikely the lucrative respiratory product will return to the market this year.
“Formal partnership” connects Michigan State's clinical and research expertise with Perrigo's product innovation, manufacturing scale and retail distribution network, Despite breadth and depth of Perrigo’s product lineup, it expects another $1b annually could come from segments where it has no or little market share.
Pfizer, Sanofi, Bristol Myers Squibb, Gilead’s Kite, Lilly’s Dermira, Janssen and Biogen among the major companies announcing transactions this week.
- Gene Therapy, Cell Therapy